The 'other' bone sarcomas: Prognostic factors and outcomes of spindle cell sarcomas of bone

Journal of Bone and Joint Surgery - Series B

Volumn 93 B, Issue 9, 2011, Pages 1271-1278

  Pakos, E E ^a,b   Grimer, R J ^a,c   Peake, D ^a,c   Spooner, D ^a,c   Carter, S R ^a   Tillman, R M ^a   Abudu, S ^a   Jeys, L ^a  

^a ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; AGE; AGED; AMPUTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHILD; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; FEMUR; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMERUS; LEIOMYOSARCOMA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MEDICAL HISTORY; METASTASIS; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PALLIATIVE THERAPY; PATHOLOGIC FRACTURE; PELVIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RADIATION INDUCED NEOPLASM; SCHOOL CHILD; SPINDLE CELL SARCOMA; SPINDLE CELL SARCOMA OF BONE; SURVIVAL RATE; TIBIA; TIME; TREATMENT RESPONSE;

ADULT; AGED; BONE NEOPLASMS; CASE-CONTROL STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; OSTEOSARCOMA; PROGNOSIS; RISK FACTORS; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80052798321     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.93B9.27166     Document Type: Article

References (24)

1. Fletcher CDM, Unni KK, Mertens F. World Health Organization classification of tumours: pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002:225-32.
2. Papagelopoulos PJ, Galanis E, Frassica FJ, et al. Primary fibrosarcoma of bone: outcome after primary surgical treatment. Clin Orthop 2000;373:88-103. (Pubitemid 30225663)
3. Capanna R, Bertoni F, Bacchini P, et al. Malignant fibrous histiocytoma of bone: the experience at the Rizzoli Institute: report of 90 cases. Cancer 1984;54:177-187. (Pubitemid 14117066)
4. Huvos AG, Heilweil M, Bretsky SS. The pathology of malignant fibrous histiocytoma of bone: a study of 130 patients. Am J Surg Pathol 1985;9:853-871. (Pubitemid 16175002)
5. Nishida J, Sim FH, Wenger DE, Unni KK. Malignant fibrous histiocytoma of bone: a clinicopathologic study of 81 patients. Cancer 1997;79:482-493. (Pubitemid 27051772)
6. Bramwell VH, Steward WP, Nooij M, et al. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: a European Osteosarcoma Intergroup study. J Clin Oncol 1999;17:3260-3269. (Pubitemid 29470661)
7. Sundaram M, Akduman I, White LM, et al. Primary leiomyosarcoma of bone. AJR Am J Roentgenol 1999;172:771-776. (Pubitemid 29102152)
8. Nooij MA, Whelan J, Bramwell VH, et al. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. Eur J Cancer 2005;41:225-230. (Pubitemid 40126954)
9. Sobin LH, Wittekind C.TNM classification of malignant tumors. Sixth ed. New York: Wiley, 2002.
10. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
11. Kaplan EL, Meier P. Nonparametric observations from incomplete observations. J Am Stat Assoc 1958;53:457-481.
12. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980;153:106-120. (Pubitemid 11217753)
13. Bramwell VH, Burgers M, Sneath R, et al. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992;10:1579-1591. (Pubitemid 23057988)
14. Souhami RL, Craft AW, Van der Eijken JW, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997;350:911-917. (Pubitemid 27420527)
15. Lewis IJ, Nooij MA, Whelan J, et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007;99:112-128.
16. Grimer RJ, Cannon SR, Taminiau AM, et al. Osteosarcoma over the age of forty. Eur J Cancer 2003;39:157-163. (Pubitemid 36057064)
17. Petra M, Gibbons CL, Athanasou NA. Leiomyosarcoma of bone arising in association with a bone infarct. Sarcoma 2002;6:47-50. (Pubitemid 34620888)
18. Wirbel RJ, Verelst S, Hanselmann R. Primary leiomyosarcoma of bone: clinicopathologic, immunohistochemical, and molecular biologic aspects. Ann Surg Oncol 1998;5:635-641. (Pubitemid 28523253)
19. Myers JL, Arocho J, Bernreuter W, Dunham W, Mazur MT. Leiomyosarcoma of bone: a clinicopathologic, immunohistochemical, and ultrastructural study of five cases. Cancer 1991;67:1051-1056.
20. Evans HL, Raymond AK, Ayala AG. Vascular tumours of bone: a study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma. Hum Pathol 2003;34:680-689. (Pubitemid 36875514)
21. Earl HM, Pringle J, Kemp H, et al. Chemotherapy of malignant fibrous histiocytoma of bone. Ann Oncol 1993;4:409-415. (Pubitemid 23193107)
22. Bielack SS, Schroeders A, Fuchs N, et al. Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases: European Musculo-Skeletal Oncology Society. Acta Orthop Scand 1999;70:353-360. (Pubitemid 29497471)
23. Bacci G, Avella M, Picci P, et al. The effectiveness of chemotherapy in localized malignant fibrous histiocytoma (MFH) of bone: the Rizzoli Institute experience with 66 patients treated with surgery alone or surgery + adjuvant or neoadjuvant chemotherapy. Chemioterapia 1988;7:406-413. (Pubitemid 19039758)
24. Waddell AE, Davis AM, Ahn H, et al. Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone: comparison of treatment and control groups. Can J Surg 1999;42:190-199. (Pubitemid 29274649)